Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 690 of 1,261
  1. US 9360446

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Aytu BioScience, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  2. US 9359437

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  3. US 9359429

    Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof

    PROTEIN DESIGN LAB, LTD. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  4. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  5. US 9359380

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  6. US 9359410

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  7. US 9359360

    TLR agonists

    The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  8. US 9359309

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  9. US 9359196

    Antiproliferative compositions comprising curcumin analogs and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  10. US 9358287

    Method of treating stress hyperglycemia with human antibodies to the glucagon receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  11. US 9358283

    Diatom-based vaccines

    The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  12. US 9358249

    Use of Pateamine A for the treatment of age-related muscle wasting

    The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  13. US 9358240

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  14. US 9357924

    Composition, method, system and kit for optical electrophysiology

    UNIVERSITY OF CONNECTICUT · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  15. WO 2016085392

    DÉRIVÉS DE BIS (SULFONAMIDE) ET LEUR UTILISATION COMME INHIBITEURS DE MPGES

    ACTURUM LIFE SCIENCE AB [SE] · Granted Jun 2, 2016 · Expires May 28, 2036

    granted
  16. WO 2016085391

    DÉRIVÉS DE BIS (SULFONAMIDE) ETLEUR UTILISATION COMME INHIBITEURS DE MPGES

    ACTURUM LIFE SCIENCE AB [SE] · Granted Jun 2, 2016 · Expires May 28, 2036

    granted
  17. EP 3024825

    IMIDAZOLECARBOXAMIDE UND IHRE VERWENDUNG ALS FAAH INHIBITOREN

    BIAL PORTELA & CA SA [PT] · Granted Jun 1, 2016 · Expires May 27, 2036

    granted
  18. US 9353075

    Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

    The Regents of the University of California · Granted May 31, 2016 · Expires May 26, 2036

    granted
  19. US 9353124

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  20. US 9352015

    Antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted May 31, 2016 · Expires May 26, 2036

    granted
  21. US 9351970

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  22. US 9353112

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  23. US 9353176

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  24. US 9353372

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.